Hepatic necroinflammatory activity and serum alanine aminotransferase
| . | HCV−patients . | HCV+patients . | P for HCV− versus HCV+ . | |||||
|---|---|---|---|---|---|---|---|---|
| Entry . | Final . | P . | Entry . | Final . | P . | Entry . | Final . | |
| Mean Ishak activity grade, all pathologists4-150 | 0.42 ± 0.70 | 0.55 ± 0.58 | .60 (n = 11) | 1.64 ± 1.43 | 2.06 ± 1.75 | .06 (n = 45) | .0003 | < .0001 |
| Serum ALT (IU/L)4-151 | 16.5 ± 6.4 | 24.5 ± 13.3 | .09 | 52.0 ± 72.8 | 66.2 ± 61.3 | .34 | .003 | .0003 |
| . | HCV−patients . | HCV+patients . | P for HCV− versus HCV+ . | |||||
|---|---|---|---|---|---|---|---|---|
| Entry . | Final . | P . | Entry . | Final . | P . | Entry . | Final . | |
| Mean Ishak activity grade, all pathologists4-150 | 0.42 ± 0.70 | 0.55 ± 0.58 | .60 (n = 11) | 1.64 ± 1.43 | 2.06 ± 1.75 | .06 (n = 45) | .0003 | < .0001 |
| Serum ALT (IU/L)4-151 | 16.5 ± 6.4 | 24.5 ± 13.3 | .09 | 52.0 ± 72.8 | 66.2 ± 61.3 | .34 | .003 | .0003 |